Pfizer asks FDA to authorize third dose for children 5 to 11 years old
Dr. Sandra Hughes prepares to administer a first dose of the Pfizer-BioNTech coronavirus vaccine (COVID-19) to Elise Langevina, 6, in Storrs, Connecticut, U.S., November 3, 2021.
Michelle McLoughlin | Reuters
Pfizer on Tuesday asked the Food and Drug Administration to authorize a third dose of its Covid vaccine for children ages 5- to 11-years-old.
The application comes after Pfizer released clinical trial data earlier this month showing that blood samples from 30 kids in the age group had a 36-fold increase in antibody levels against the omicron variant compared to two doses of the vaccine.
This is breaking news. Please check back for updates.